✦ LIBER ✦

156: Treatment of Myeloid Malignancies in Elderly Patients with Fludarabine and Targeted Busulfan (t-Bu) and Allogeneic Hematopoietic Cell Transplantation (HCT)

✍ Scribed by H.F. Fernandez; A.M. Henao-Uribe; W.H. Poling; J.C. Chavez; M. Alsina; E. Ayala; T. Field; M. Kharfan-Dabaja; L. Perez; J. Raychaudhuri; L. Ochoa-Bayona; C. Anasetti

Book ID: 116279984
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 50 KB
Volume: 14
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2007.12.165

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low Dose Thymoglobulin Result in Improve

Low Dose Thymoglobulin Result in Improved Outcomes after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) for Patients with Acute Myeloid Leukemia/ Myelodysplastic Syndrome Conditioned with Intravenous Busulfan and Fludarabine

✍ Matar, Abraham J.; Fondaw, Megan; Smith, Tori; Balls, Jason; Solh, Melhem; Khale 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 173 KB

278: Treosulfan Plus Fludarabine for All

278: Treosulfan Plus Fludarabine for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Acute Leukemia and Myelodysplastic Syndrome

✍ E.R. Nemecek; B. Ly; T. Kovacsovics; R.T. Maziarz; J. Baumgart; J.E. Sanders; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

304: Effect of Substituting Fludarabine

304: Effect of Substituting Fludarabine and Thymoglobulin for Cyclophosphamide in Busulfan-based Conditioning Regimens on T-cell Chimerism and outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)

✍ P.V. O'Donnell; A.E. Woolfrey; B. Storer; M.L. Sorror; T. Furlong; C. Anasetti; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Modified Busulfan and Cyclophosphamide C

Modified Busulfan and Cyclophosphamide Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Patients With Hematologic Malignancies

✍ Zhao, X.F.; Mao, X.Y.; Wan, D.M.; Liu, W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Reduced-Intensity Conditioning Allogenei

Reduced-Intensity Conditioning Allogeneic Blood Stem Cell Transplantation with Fludarabine and Oral Busulfan with or without Pharmacokinetically Targeted Busulfan Dosing in Patients with Myeloid Leukemia Ineligible for Conventional Conditioning

✍ Rodrigo Martino; José A. Pérez-Simón; Estela Moreno; José M. Queraltó; Dolores C 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Non-Myeloablative (NMA) Allogeneic Hemat

Non-Myeloablative (NMA) Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine and Total Body Irradiation (Bu/Flu/TBI) Conditioining: Results of a Phase II Trial

✍ Brammer, Jonathan E.; Stentz, Alex; Dibb, James; Frires, Rachel; Meyers, Gabriel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB